The advertisement promotes Nucala (mepolizumab) as a treatment option for chronic obstructive pulmonary disease (COPD), highlighting its potential benefits and safety information.
Creative Information
| CID: | 045ba51a-2bce-4ab9-8e1f-82c1202a3541 |
| CRID: | 89_219809 |
| Domain: | nucala.com |
| Seat: | DInt |
| Size: | 300x600 |
| Bid: | $2.61 |
| Timestamp: | 11/17/2025, 5:55:07 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/17/2025, 6:11:24 PM | 6.25s | |
| adomain_analysis | success | 11/17/2025, 7:53:41 PM | 8.98s | |
| adomain_capture | success | 11/17/2025, 7:53:32 PM | 0.25s | |
| ad_render | success | 11/17/2025, 6:11:18 PM | 27.47s | |
| brand_mapping | success | 11/17/2025, 5:55:08 PM | 0.22s | |
Analysis Results
| Size: | 300x600 | ||||||||||||||||||||||
| Data Transferred: | 1667.71 KB | ||||||||||||||||||||||
| Render Time: | 9.11 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | Domain:www.nucala.com Brand: | ||||||||||||||||||||||
| Total Ad Size: | 1688.83 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


